Connect

"We are interested in understanding how different mutations associated with blood cancer contribute to the disease. Our ultimate goal is to find new therapeutic targets and develop novel therapies for leukemias."

— Golam Mohi, PhD, Professor, Department of Biochemistry and Molecular Genetics and Co-Leader of the Hematological Malignancies Translational Research team at the UVA Cancer Center